ID: ALA2431071

Max Phase: Preclinical

Molecular Formula: C25H29N3O7S

Molecular Weight: 515.59

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@@H](O)[C@H]1C(=O)N2C3=C(S[C@@H]4CN[C@@H](C4)C(=O)Nc4cccc(c4)C(=O)OCCCOC3=O)[C@H](C)[C@H]12

Standard InChI:  InChI=1S/C25H29N3O7S/c1-12-19-18(13(2)29)23(31)28(19)20-21(12)36-16-10-17(26-11-16)22(30)27-15-6-3-5-14(9-15)24(32)34-7-4-8-35-25(20)33/h3,5-6,9,12-13,16-19,26,29H,4,7-8,10-11H2,1-2H3,(H,27,30)/t12-,13-,16+,17+,18-,19-/m1/s1

Standard InChI Key:  HFFBFNZMWTYVKV-CELYIQNJSA-N

Associated Targets(Human)

Plasma 7708 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasma 810 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Plasma 280 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Canis familiaris 36305 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Plasma 10718 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 515.59Molecular Weight (Monoisotopic): 515.1726AlogP: 1.26#Rotatable Bonds: 1
Polar Surface Area: 134.27Molecular Species: BASEHBA: 9HBD: 3
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.98CX Basic pKa: 8.99CX LogP: -0.02CX LogD: -1.61
Aromatic Rings: 1Heavy Atoms: 36QED Weighted: 0.37Np Likeness Score: 0.74

References

1. Singh SB, Rindgen D, Bradley P, Cama L, Sun W, Hafey MJ, Suzuki T, Wang N, Wu H, Zhang B, Wang L, Ji C, Yu H, Soll R, Olsen DB, Meinke PT, Nicoll-Griffith DA..  (2013)  Design, synthesis, and evaluation of prodrugs of ertapenem.,  (8): [PMID:24900737] [10.1021/ml400092n]
2. Singh SB, Rindgen D, Bradley P, Suzuki T, Wang N, Wu H, Zhang B, Wang L, Ji C, Yu H, Soll RM, Olsen DB, Meinke PT, Nicoll-Griffith DA..  (2014)  Design, synthesis, structure-function relationship, bioconversion, and pharmacokinetic evaluation of ertapenem prodrugs.,  57  (20): [PMID:25265501] [10.1021/jm500879a]

Source